The FDA-approved smoking cessation pill, varenicline, has emerged as a groundbreaking solution for those struggling to quit vaping, especially among teens and young adults.Recent research from Mass General Brigham highlights that individuals aged 16 to 25 who used varenicline were more than three times more likely to successfully stop vaping compared to those receiving only behavioral counseling.